Interrelationship between procalcitonin and organ failure in sepsis

Indian Journal of Clinical Biochemistry

Volumn 29, Issue 1, 2014, Pages 93-96

  Anand, Dimple ^a   Das, Sabari ^a   Ray, Sumit ^a   Bhargava, Seema ^a   Srivastava, Lalit Mohan ^a  

^a SIR GANGA RAM HOSPITAL   (India)

Author keywords

Biomarker; Organ dysfunction; Procalcitonin; Prognosis; Sepsis

Indexed keywords

EID: 84895070260     PISSN: 09701915     EISSN: 09740422     Source Type: Journal    
DOI: 10.1007/s12291-013-0326-z     Document Type: Article

References (17)

1. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341:515-8.
2. Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med. 2000;26(Suppl 2):S148-52.
3. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection and sepsis: clinical utility and limitations. Crit Care Med. 2008;36(3):941-52.
4. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79:1605-8.
5. Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis related cytokines in vitro. J Lab Clin Med. 1999;134:49-55.
6. Muller B, White JC, Nylen ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001;86:396-404.
7. Reinhart K, Meisner M. Biomarkers in the critically ill patient: procalcitonin. Crit Care Clin. 2011;27:253-63.
8. Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C reactive protein as markers of sepsis. Crit Care Med. 2003;1:1737-41.
9. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-74.
10. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter prospective study. Working group on "sepsis related problems" of the European society of Intensive Care Medicine. Crit Care Med. 1998;26:1793-800.
11. Khilnani GC, Hadda V. Management of severe sepsis: role of "bundles". Indian J Chest Dis Allied Sci. 2009;51:27-36.
12. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. New Engl J Med. 2003;348:1546-54.
13. Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, et al. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA. 1997;278:234-40.
14. Anand D, Das S, Srivastava LM. Procalcitonin - a novel sepsis biomarker. Asian J Med Res. 2012;1:6-8.
15. Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med. 2006;34:2596-602.
16. Rammaert B, Verdier N, Cavestri B, Nseir S. Procalcitonin as a prognostic factor in seven acute exacerbation of chronic obstructive pulmonary disease. Respirology. 2009;14:969-74.
17. Hillas G, Vassilakopoulos T, Plantza P, Rasidakis A, Bakakos P. C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator associated pneumonia. Eur Respir J. 2010;4:805-11.